Nicox

en fr

About Us
Pipeline, Markets and Science
Investors
News and Events
Contact Us

Nicox’s partner Bausch + Lomb initiates phase 2b study with glaucoma drug-candidate BOL-303259-X (NCX 116)

November 14, 2010

← Back to blog page

Nicox

Contact Us
Subscribe to news
Legal Notice

Search

© Copyright Nicox, all rights reserved

Cookies

By continuing to use this website, you agree to our Cookie Policy.